ArticleMolecular therapy. Oncology2025

Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement.

Erika A K Fletcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.